Status | Study |
Recruiting |
Study Name: Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome Condition: Cushing's Syndrome Date: 2014-11-19 Interventions: Drug: metyrapone Single arm study Other Name: Metopi |
Recruiting |
Study Name: Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome Condition: Cushing Syndrome Date: 2013-12-21 Interventions: Drug: F-DOPA PET Scan Drug: Mifepristone |
Recruiting |
Study Name: Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism Condition: Hypercortisolism Cushing Syndrome Date: 2013-11-27 Interventions: Procedure: Adrenalectomy Surgi |
Recruiting |
Study Name: Treatment for Endogenous Cushing's Syndrome Condition: Endogenous Cushing's Syndrome Date: 2013-04-19 Interventions: Drug: COR-003 |
Completed |
Study Name: Pattern of Gene Expression in Adipose Tissue From Patients With Cushing Syndrome Condition: Cushing Syndrome Related to Cortisolic Adenoma Date: 2012-08-02 Interventions: Other: analyze the role of glucocorticoid in AT distribution. |
Recruiting |
Study Name: Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma Condition: Cushing Syndrome Date: 2011-05-30 Interventions: Procedure: surgery adrenalectomy |
Completed |
Study Name: An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome Condition: Cushing's Syndrome Date: 2009-07-09 Interventions: Drug: mifepristone Mifepristone 300 mg to 1200 mg once daily |
Terminated |
Study Name: A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia Condition: Cushing's Syndrome Date: 2008-11-20 Interventions: Drug: Cushing's syndrome confirmation Other Name: Provide access to standard test procedures. |
Completed |
Study Name: A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome Condition: Cushing's Syndrome Date: 2007-12-05 Interventions: Drug: mifepristone Patients take mifepristone by mouth once a day. The dose is increased during schedule |
Terminated |
Study Name: Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion Condition: Cushing's Syndrome Date: 2007-01-12 Interventions: Drug: Mifepristone Singe dose |